Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# Symphony

## Sitemaps

- [XML Sitemap](https://thesymphonyprogram.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [News](https://thesymphonyprogram.com/news/)
- [Charting New Frontiers: The Impact of Gene and Cell Therapy on Healthcare](https://thesymphonyprogram.com/webinars-podcasts/charting-new-frontiers-the-impact-of-gene-and-cell-therapy-on-healthcare/) - Dr. Carolina Escobar and Dr. Oscar Bronsther explore the revolutionary world of gene and cell therapy with Spencer on the Self-Funded Podcast. Discover how these innovative treatments offer hope for rare diseases and what it means for healthcare funding. With discussions on CRISPR technology, ethical concerns, and equitable access, this episode sheds light on the
- [INTERLINK Premier Medical Round Table 'Gene Therapy Has Arrived What Does the Future Hold'](https://thesymphonyprogram.com/webinars-podcasts/interlink-premier-medical-round-table-gene-therapy-has-arrived-what-does-the-future-hold/)
- [Sickle Cell Gene Therapy Discussion](https://thesymphonyprogram.com/webinars-podcasts/sickle-cell-gene-therapy-discussion/) - Discussing the newly approved sickle cell gene therapy drugs and the current state of gene and cell therapy
- [Gene and Cell Therapy Drug FDA Approval](https://thesymphonyprogram.com/news/gene-and-cell-therapy-drug-fda-approval/) - Breaking News! Pfizer Inc. has just received FDA approval for Beqvez™, a groundbreaking gene therapy for adults with moderate to severe hemophilia B. Beqvez offers a life-changing treatment option for those who currently use factor IX prophylaxis therapy or have experienced serious bleeding episodes and is currently priced at $3.5 millionAt Symphony Benefits Solution, we
- [New FDA Approval Announced for Breyanzi](https://thesymphonyprogram.com/news/new-fda-approval-announced-for-breyanzi/) - UPDATE: A New FDA approval has been released for Breyanzi. A request was submitted for approval for the expanded indication to include Relapsed and Refractory (R/R) Follicular Lymphoma and Marginal Zone Lymphoma with a PDUFA date of 5/23. Only the Follicular Lymphoma has been approved so far, so we are still anxiously awaiting a decision on
- [FDA Approval of G&C Therapy Drug Update](https://thesymphonyprogram.com/news/fda-approval-of-gc-therapy-drug-update/) - Another new FDA approval expanding the indication for Abecma. Previously, it was approved only after failure of 4 or more prior lines of therapy. However, due to showing a progression-free survival benefit 3 times that of standard regimens, it is now approved for use after only 2 lines of previous therapy. Navigating the complexities of
- [Understanding Gene & Cell Therapy with Symphony Benefits Solution](https://thesymphonyprogram.com/webinars-podcasts/understanding-gene-cell-therapy-with-symphony-benefits-solutions/) - Dive into the world of gene and cell therapy with Symphony Benefits Solution and discover how these groundbreaking treatments are revolutionizing healthcare by altering genetic material and transplanting healthy cells to combat various diseases. Learn about the real-life impact on patients, the exciting future prospects of personalized medicine, and the innovative solutions addressing the challenges
- [Updates on Failed FDA Approvals in the Gene and Cell Therapy Drug Space](https://thesymphonyprogram.com/news/updates-on-failed-fda-approvals-in-the-gene-and-cell-therapy-drug-space/) - The recent failure of Pfizer's late-stage trial for Duchenne muscular dystrophy (DMD) gene therapy marks a significant setback for patients but opens the door for competitors like Sarepta Therapeutics. Pfizer’s gene therapy did not improve motor function in young boys and follows a similar setback for Sarepta’s Elevidys. Despite this, Sarepta remains optimistic, citing positive
- [Exciting advancements are on the horizon for Gene & Cell Therapies](https://thesymphonyprogram.com/news/exciting-advancements-are-on-the-horizon-for-gene-cell-therapies/) - Exciting advancements are on the horizon for Gene & Cell Therapies, particularly in the realm of treating hematologic and rare diseases. The anticipation surrounding the FDA approvals expected in 2024 is palpable, with each approval holding the potential to impact patient populations significantly. As INTERLINK® draws closer to the launch of Symphony Benefits Solution, we're
- [Gene Therapy Economics: Understanding the Real Price Tag](https://thesymphonyprogram.com/news/gene-therapy-economics-understanding-the-real-price-tag/) - Orchard's recent reveal of Lenmeldy's $4.25 million price tag has sparked conversations about the affordability of groundbreaking gene therapies. While Lenmeldy stands as the most expensive one-time gene therapy, it's important to broaden our view beyond headline figures. Lesser-known treatments like Zokinvy and Myalept, which are administered monthly, quietly accumulate costs that rival or exceed
- [INTERLINK COE Networks & programs announces the launch of Symphony Benefits Solution on July 1, 2024](https://thesymphonyprogram.com/webinars-podcasts/interlink-coe-networks-programs-announces-the-launch-of-symphony-benefits-solution-on-july-1-2024/) - Symphony Benefits Solution is the industry’s first fullyintegrated solution for high-cost benefits, including Transplant, Cancer,ESRD/Dialysis, and Gene & Cell Therapies into a single program.This informative webinar will discuss: An overview of the latest enhancements to the CancerCARE program. Introduction of medical management to the established transplant network and our strategy to utilize our performance-narrowed network with

## Pages

- [Home](https://thesymphonyprogram.com/) - Empowering Lives with Leading-Edge Benefits At Symphony Benefits Solution, we leverage cutting-edge technology and innovative solutions to provide comprehensive healthcare benefits for transplant, cancer, ESRD, and gene & cell therapy. Our commitment to excellence ensures that you receive the highest standard of care and support. contact us Gene & Cell Therapy CancerCARE Transplant CKD/ESRD/Dialysis Combined
- [About](https://thesymphonyprogram.com/about/) - Meet Symphony: Your Partner in Advanced Health Benefits For over two decades, Symphony’s parent company INTERLINK® has led the way in enhancing patient outcomes by integrating local care with national Centers of Excellence. Our journey began with complex transplants and expanded to pioneering cancer treatments. We empower members with access to cutting-edge clinical trials and
- [Request Medical Review](https://thesymphonyprogram.com/request-review/) - Please fill out the form below to receive a sample medical report via email. PhoneThis field is for validation purposes and should be left unchanged.NameEmail PhoneMessageCAPTCHA Submit
- [Contact](https://thesymphonyprogram.com/contact/) - Contact Us Get in touch to explore our healthcare solutions. (615)535-1830 info@thesymphonyprogram.com 4660 NE Belknap Court, Suite 209 Hillsboro, Oregon 97124 Please use the form below to get in touch with us for any product inquiries or support. InstagramThis field is for validation purposes and should be left unchanged.NameCompanyEmail PhoneWhich Symphony programs are you interested
- [Gene & Cell Therapy](https://thesymphonyprogram.com/services/gene-cell-therapy/) - Advanced Care. Personalized Treatment. Proven Results Symphony’s Gene & Cell Therapy (GCT) program revolutionizes patient care through cutting-edge genetic and cellular innovations. While NCCN Guidelines exist for Cellular therapy, standardized Guidelines are unavailable for Gene therapy. Our expert medical team has written proprietary evidence-based Guidelines considering FDA approval information and Inclusion and exclusion criteria from
- [Combined Services](https://thesymphonyprogram.com/services/combined-services/) - Comprehensive Benefit Solutions for High-Cost Care At Symphony, we understand the complexities and challenges associated with high-cost, low-frequency medical procedures. Our Combined Services approach provides robust, cost-effective solutions through specialized benefit plan language, meticulous medical management, and data-driven program evaluations. By implementing clear and precise benefit plan language, we ensure compliance and consistency, facilitating efficient
- [CKD/ESRD/Dialysis](https://thesymphonyprogram.com/services/ckd-esrd-dialysis/) - Proactive Kidney Care. Optimal Outcomes. Trusted Expertise. Our CKD/ESRD/Dialysis program provides comprehensive solutions to manage and reduce the impact of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Utilizing our proprietary risk identification algorithms, we uncover and address hidden CKD risks before they escalate. Our proactive approach combines early detection with specialized clinical interventions
- [Transplant](https://thesymphonyprogram.com/services/transplant/) - Leading-Edge Care. Timely Transplants. Exceptional Results. The Symphony Transplant program is designed to deliver superior patient outcomes through specialized case management and a performance-narrowed network of top-performing transplant centers. Our program offers a comprehensive approach to both pre- and post-transplant care, ensuring patients receive the best possible treatment and support throughout their journey. Learn More
- [CancerCARE](https://thesymphonyprogram.com/services/cancercare/) - Right Care. Right Time. Right Place Welcome to Symphony’s CancerCARE program, where we provide a holistic and evidence-based approach to cancer treatment and support. Established in 2012, our program is designed to guide plan members through every stage of their cancer journey, from initial diagnosis to survivorship.Our CancerCARE program ensures that 95% of patients receive
- [Services](https://thesymphonyprogram.com/services/) - Integrated Benefits for Advanced Healthcare Services Expert Solutions in Cancer, CKD/ESRD/Dialysis, Gene & Cell Therapy, and Transplant Care Learn more CancerCARE Evidence-based cancer management offering advanced treatments and supportive care services. Explore now > CKD/ESRD/Dialysis Early detection and intervention programs to manage chronic kidney disease and dialysis needs effectively. Explore now > Gene & Cell
- [Privacy Policy](https://thesymphonyprogram.com/privacy-policy/) - THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.Uses and DisclosuresTreatmentYour health information may be used by staff members or disclosed to other health care professionals for the purpose of evaluating your health, diagnosing medical conditions, and providing

## Testimonials

- [CancerCare 7](https://thesymphonyprogram.com/testimonials/cancercare-7/)
- [Transplant 1](https://thesymphonyprogram.com/testimonials/transplant-1/)
- [CancerCare 6](https://thesymphonyprogram.com/testimonials/cancercare-6/)
- [CancerCare 5](https://thesymphonyprogram.com/testimonials/cancercare-5/)
- [CancerCare 4](https://thesymphonyprogram.com/testimonials/cancercare-4/)
- [CancerCare 3](https://thesymphonyprogram.com/testimonials/cancercare-3/)
- [CancerCare 2](https://thesymphonyprogram.com/testimonials/cancercare-2/)
- [CancerCare 1](https://thesymphonyprogram.com/testimonials/cancercare-1/)
- [Renlogic B2B 4](https://thesymphonyprogram.com/testimonials/renlogic-b2b-4/)
- [Renalogic B2B 3](https://thesymphonyprogram.com/testimonials/renalogic-b2b-3/)
- [Renalogic B2B 2](https://thesymphonyprogram.com/testimonials/renalogic-b2b-2/)
- [Renalogic B2B 1](https://thesymphonyprogram.com/testimonials/renalogic-b2b-1/)
- [Renalogic 4](https://thesymphonyprogram.com/testimonials/renalogic-4/)
- [Renalogic 3](https://thesymphonyprogram.com/testimonials/renalogic-3/)
- [Renalogic 2](https://thesymphonyprogram.com/testimonials/renalogic-2/)
- [Renalogic 1](https://thesymphonyprogram.com/testimonials/renalogic-1/)

## Categories

- [Webinars & Podcasts](https://thesymphonyprogram.com/category/webinars-podcasts/)
- [News](https://thesymphonyprogram.com/category/news/)

## Testimonial Categories

- [Renalogic](https://thesymphonyprogram.com/testimonial-category/renalogic/)
- [Renalogic B2B](https://thesymphonyprogram.com/testimonial-category/renalogic-b2b/)
- [CancerCare](https://thesymphonyprogram.com/testimonial-category/cancercare/)
- [Transplant](https://thesymphonyprogram.com/testimonial-category/transplant/)